DEF 14AThe Ballot
Maze Therapeutics, Inc. files DEF 14A
Filed Apr 28, 2026 · 2mo ago · Accession 0001140361-26-017463
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Maze Therapeutics, Inc.
- Ticker
- MAZE
- CIK
- 1842295
- Form type
- DEF 14A
- Filing date
- Apr 28, 2026
- Report date
- Jun 8, 2026
- Document
- ef20071652_def14a.htm
- Size
- 2.9 MB